Adial Pharmaceuticals (ADIL) Financials: Revenue & Earnings

ADIL price $4.35 +0.64 +17.25%

Ticker
ADIL
Price
$4.35
Change
+0.64 +17.25%
Market cap ?
$11.42M
P/E ?
-0.24
Forward P/E ?
10.36
Dividend yield ?
0.00%
Beta ?
1.50
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
70
Value
59
Quality
52
Growth
100

Stocklytics score rationale: value 59, quality 52, growth 100.

Financials

2016201720182019202020212022202320242025
0000000000

Adial Pharmaceuticals, Inc. is a biopharmaceutical enterprise operating at the clinical stage, dedicated to researching and developing innovative therapeutic options for the management and prevention of addiction and associated disorders. Its primary investigational compound, AD04, functions as a selective serotonin-3 antagonist and is currently undergoing pivotal Phase III clinical trials for the treatment of…

Fair value

ADIL fair value $16.26. Price $4.35. Price is 73% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare ADIL

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-18—-0.17——
2026-08-12-11.25-1.03——
2026-05-13-1.48-2.73——
2026-03-10-1.81-2.10——
2025-11-13-2.00-2.25——
2025-08-13-4.50-5.50——
2025-05-14-8.50-12.50——
2025-03-04-3.75-9.50——
2024-11-13-9.50-12.50——
2024-08-13-14.75-0.53——
2024-05-14-17.00-0.51——
2024-04-04-1.35-0.76——
2023-11-14-28.50-28.50——
2023-08-21-33.25-1.50——
2023-05-12-2.62-0.14——
2023-03-30-68.75-3.83——
2022-11-14-3.00-0.18——
2022-08-16-100.00-100.00——
2022-05-16-81.25-106.25——
2022-03-28-175.00-5.12——
2021-11-15-137.50-137.50——
2021-08-12-156.25-0.20——
2021-05-17-187.50———
2021-03-22-150.00-0.25——
2020-11-13-150.00-0.18——
2020-08-13-100.00-0.18——
2020-05-14-137.50———
2020-03-20-118.75———
2019-11-14-106.25———
2019-08-13-131.25-0.18——
2019-05-13-0.27-0.17——
2019-02-19-0.27-0.18——
2018-11-14-0.85-0.26——
2018-07-30-171.25———
2018-03-31-49.53———
2017-12-31-46.12———
2017-09-30-33.40———
2017-06-30-34.54———
2017-03-31-23.34———
2016-12-31-12.48———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-17Young Wendy B.Buy25.67K$2.9876.48K
2026-07-16Coastlands Capital LPBuy1.23K$2.753.39K
2026-07-14Coastlands Capital LPBuy2.00K$2.655.30K
2026-07-10Coastlands Capital LPBuy1.70K$2.704.59K
2026-07-09Coastlands Capital LPBuy10.05K$2.7928.05K
2026-06-29Coastlands Capital LPBuy25.00K$2.6065.00K
2026-06-24Coastlands Capital LPOther0——
2026-06-24Coastlands Capital LPOther3.64M$0.003.64K
2026-06-12Davidson MattBuy232.42K——
2026-06-12Davidson MattBuy232.42K$2.89671.69K
2026-06-12Young Wendy B.Buy36.38K$0.0036
2026-06-11Davidson MattBuy61.65K——
2026-06-11Davidson MattBuy3.43K——
2026-06-11Davidson MattBuy101——
2026-06-11Davidson MattBuy1.82K——
2026-06-11Davidson MattOther0——
2026-06-11Young Wendy B.Other0——
2026-04-07Goodman TonyBuy26.51K——
2026-04-07Anderson J. KermitBuy9.19K$1.6415.06K
2026-04-07Schuyler KevinBuy9.19K——
2026-04-07Shah VinayBuy17.32K——
2026-04-07Gilliland Robertson H.Buy9.19K——
2026-04-07Claiborne Cary JBuy37.98K——
2025-05-29Gilliland Robertson H.Buy28.00K$0.6919.26K
2025-05-29Newman James W. Jr.Buy28.00K$0.6919.26K
2025-05-29Shah VinayBuy9.00K$0.696.19K
2025-05-29Schuyler KevinBuy28.00K$0.6919.26K
2025-05-29Claiborne Cary JBuy138.00K$0.6994.94K
2025-05-29Goodman TonyBuy94.00K$0.6964.67K
2025-05-29Anderson J. KermitBuy28.00K$0.6919.26K
2024-12-05Claiborne Cary JBuy350.00K$1.15402.50K
2024-11-16Shah VinayBuy40.00K$1.0642.40K
2024-11-16Shah VinayOther0——
2024-03-25Gilliland Robertson H.Buy12.00K$1.3516.20K
2024-03-25Newman James W. Jr.Buy12.00K$1.3516.20K
2024-03-25Truluck JosephBuy25.00K$1.3533.75K
2024-03-25Claiborne Cary JBuy60.00K$1.3581.00K
2024-03-25Anderson J. KermitBuy12.00K$1.3516.20K
2024-03-25Schuyler KevinBuy12.00K$1.3516.20K
2024-03-25Goodman TonyBuy42.00K$1.3556.70K
2023-09-29Schuyler KevinBuy700$2.741.92K
2023-05-23Johnson Bankole A.Buy40.00K$0.3012.10K
2023-05-23Truluck JosephBuy157.50K——
2023-05-23Truluck JosephBuy125.00K$0.3037.81K
2023-05-23Stilley William B. IIIBuy240.80K——
2023-05-23Stilley William B. IIIBuy50.00K$0.3015.12K
2023-05-23Schuyler KevinBuy50.00K$0.3015.12K
2023-05-23Newman James W. Jr.Buy50.00K$0.3015.12K
2023-05-23Goodman TonyBuy50.00K$0.3015.12K
2023-05-23Gilliland Robertson H.Buy50.00K$0.3015.12K
2023-05-23Claiborne Cary JBuy420.00K——
2023-05-23Claiborne Cary JBuy300.00K$0.3090.75K
2023-05-23Anderson J. KermitBuy50.00K$0.3015.12K
2022-12-30Stilley William B. IIISell166.67K——
2022-09-20Claiborne Cary JBuy75.00K$0.4231.52K
2022-09-19Claiborne Cary JBuy25.00K$0.4310.73K
2022-08-22Stilley William B. IIIBuy100.00K$0.5655.50K
2022-08-22Stilley William B. IIIBuy100.00K——
2022-08-18Claiborne Cary JBuy1.00M——
2022-06-27Goodman TonyBuy25.00K——
2022-02-23Johnson Bankole A.Buy35.00K$2.0070.00K
2022-02-23Goodman TonyBuy40.00K$2.0080.00K
2022-02-23Truluck JosephBuy100.00K$2.00200.00K
2022-02-23Stilley William B. IIIBuy250.00K——
2022-02-23Schuyler KevinBuy40.00K$2.0080.00K
2022-02-23Newman James W. Jr.Buy40.00K$2.0080.00K
2022-02-23Gilliland Robertson H.Buy40.00K$2.0080.00K
2022-02-23Claiborne Cary JBuy6.67K$2.0013.33K
2022-02-23Anderson J. KermitBuy40.00K$2.0080.00K
2021-12-30Newman James W. Jr.Buy5.00K$2.7213.60K
2021-12-30Newman James W. Jr.Buy10.00K$2.7127.10K
2021-12-30Newman James W. Jr.Buy10.00K$2.6626.60K
2021-12-23Schuyler KevinSell312.99K——
2021-12-23Schuyler KevinSell90.00K$6.25562.50K
2021-12-07Claiborne Cary JBuy130.00K$2.77360.10K
2021-11-30Stilley William B. IIIBuy10.60K$2.7529.18K
2021-11-29Stilley William B. IIIBuy10.00K$2.5925.89K
2021-11-26Newman James W. Jr.Buy10.00K$2.8528.50K
2021-11-02Claiborne Cary JBuy60.00K$3.15189.00K
2021-11-02Claiborne Cary JOther0——
2021-10-04Johnson Bankole A.Sell200.00K$200,000.0040.00B
2021-10-04Johnson Bankole A.Sell150.00K——
2021-04-06Johnson Bankole A.Sell150.00K$2.50375.00K
2021-02-08Truluck JosephBuy125.00K$3.11388.75K
2021-02-08Stilley William B. IIIBuy250.00K$3.11777.50K
2021-02-08Schuyler KevinBuy40.00K$3.11124.40K
2021-02-08Newman James W. Jr.Buy40.00K$3.11124.40K
2021-02-08Goodman TonyBuy40.00K$3.11124.40K
2021-02-08Gilliland Robertson H.Buy40.00K$3.11124.40K
2021-02-08Anderson J. KermitBuy40.00K$3.11124.40K
2021-01-26Stilley William B. IIIBuy201.11K——
2021-01-26Newman James W. Jr.Buy2.54K——
2021-01-26Newman James W. Jr.Buy1.19K——
2020-11-23Schuyler KevinBuy89.60K$5.00448.00K
2020-11-23Schuyler KevinBuy89.60K$6.25560.00K
2020-11-23Schuyler KevinBuy82.46K$6.25515.38K
2020-11-23Schuyler KevinBuy8.65K$7.6365.99K
2020-11-23Schuyler KevinBuy1.01K$0.015
2020-11-23Schuyler KevinSell1.01K$0.015
2020-11-23Schuyler KevinSell8.65K$7.6365.99K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 18, holders +3 vs prior quarter. Ownership 18.69%.

HolderSharesChangeChange %Value
STONEPINE CAPITAL MANAGEMENT, LLC727.56K727.56KNew1.58M
JANE STREET GROUP, LLC32.12K32.12KNew82.22K
CITADEL ADVISORS LLC29.55K29.55KNew75.64K
UBS GROUP AG19.15K19.15KNew49.02K
STONEX GROUP INC.19.70K19.70KNew35.67K
GEODE CAPITAL MANAGEMENT, LLC12.39K12.39KNew31.73K
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD.8.00K8.00KNew20.48K
VANGUARD FIDUCIARY TRUST CO5.88K00.00%15.05K
VANGUARD CAPITAL MANAGEMENT LLC5.83K5.47K+1515.24%14.93K
MANCHESTER CAPITAL MANAGEMENT LLC1.92K1.92KNew4.92K
TOWER RESEARCH CAPITAL LLC (TRC)1.42K1.42KNew3.63K
BLACKROCK, INC.304304New778
RAFFA WEALTH MANAGEMENT, LLC8300.00%212
MORGAN STANLEY5050New128
SBI SECURITIES CO., LTD.4747New120
WELLS FARGO & COMPANY/MN66New15
HARBOUR INVESTMENTS, INC.33New8
ABOUND WEALTH MANAGEMENT11New3
CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD0-15-100.00%0
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO0-4-100.00%0

Earnings and financials

Adial Pharmaceuticals, Inc. (ADIL) trades at $4.35, with a market cap of $11.42M and a trailing P/E of -0.24. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
0000000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Adial Pharmaceuticals (ADIL) Financials: Revenue & Earnings

ADIL$4.35+0.64 +17.25%

$11.42M

Market Cap

-0.24

P/E

10.36

Forward P/E

70

Score

Price History